INFevo raises more than ¥100 million for virtual-cell AI
The XtalPi-incubated company will expand its biological models and automated experimental systems.
INFevo has completed a Pre-A financing of more than ¥100 million, its second funding round in six months. Participants include LINK-X CAPITAL, Prosperity7, Huagai Capital, Huakong Fund and DT Capital Partners, with existing investors Shunwei Capital, HongShan and Songhe Capital also investing.
The company plans to use the capital to develop its OCOO virtual-cell foundation models, expand automated experiments and build research partnerships. The models predict how cells respond to drugs and genetic interventions, while laboratory results feed into subsequent predictions.
Use of funds
Develop virtual-cell foundation models, expand automated experimental feedback and build research partnerships.